Do you make dose modifications to KEYNOTE-522 regimen in the elderly?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

Would you offer an adjuvant aromatase inhibitor following capecitabine to a post menopausal patient with ER 0%/PR 5%/HER2 0 with poor tolerance to neoadjuvant chemotherapy with residual ypT2N0M0?

What approach is suggested for extended adjuvant endocrine therapy in a HR+ breast cancer?

63 Answers

How do you manage monitoring menopausal status for a premenopausal patient with DCIS on tamoxifen who would likely become post-menopausal during therapy?

1 Answers

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
TrialMatch
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service